
Peptide Sciences Review: What the Store Was, Why It Closed in March 2026, and the Clones That Replaced It
Peptide Sciences reviewed after its March 2026 shutdown: company facts, purity claims, independent test results by product, prices, shipping, no-refund policy, and the clone sites now using the name.
Peptide Sciences Review: What the Store Was, Why It Closed in March 2026, and the Clones That Replaced It
Peptide Sciences was for most of a decade the default answer to "where do Americans buy research peptides": a Nevada-addressed store with a 100-item catalog, 99% purity on every label, same-day dispatch and prices well above everyone else's. On March 6, 2026 the homepage was replaced by a three-sentence notice that the company had "voluntarily" shut down and discontinued sales. Eight months later the searches have not stopped, and the sites now answering them are not the company.
This review is therefore two things: a record of what the store actually offered, from its own help-center text and from the independent test data gathered on its vials, and a warning about the look-alikes that have appeared since. Reddit and the store's own domain could not be read directly, so buyer sentiment comes from aggregator sites, Trustpilot pages for the clones, and newsletters that covered the closure.
Key takeaway: a US-only research-peptide vendor, domain registered in 2009, shut down without notice on March 6, 2026 with orders unfulfilled and no refund process. Before closing: 99%+ purity claim backed by in-house HPLC certificates only; free shipping over $200; cards, Zelle, ACH, crypto and, late on, Venmo and Cash App after card processors cut it off; no returns of any kind. Independent testing on 123 to 130 samples passed about 60%, with ipamorelin, PT-141 and BPC-157 scoring well and retatrutide, CJC-1295 and tesamorelin badly. At least four domains have since sold under its name; none is affiliated and two have one- and two-star Trustpilot pages.
The Closure
The timeline, from sources that reported it
Late 2025 to early 2026
Semaglutide, tirzepatide, retatrutide and MK-677 removed from the catalog as "routine compliance updates"
February 27, 2026
US health secretary announces most Category 2 peptides will return to compounding eligibility; the sector's regulatory climate shifts
March 6, 2026, about 2 PM Eastern
Homepage replaced with a notice of voluntary shutdown; a prominent podcaster's post about it reaches roughly 224,000 views the same day
March 9 to 11, 2026
Industry newsletters report customers with paid, unshipped orders being told to pursue card chargebacks; store credit worthless
April 15, 2026
FDA removes twelve peptides from Category 2; the market the store left reopens for others
October 27, 2026
Domain still under company control, stating that no third party is authorized to sell its products or claim succession
No raid, indictment or lawsuit against the company has been reported by any source found. Several directories say the FDA sent a warning letter around 2023 over "healing" and "recovery" claims on BPC-157 and TB-500 pages, after which the site copy changed; the FDA's public warning-letter database shows no entry under the company's name, so that claim is unverified. The context was a sector under pressure: FDA letters to four peptide sellers in December 2024, a raid on another in June 2025, more than fifty letters to GLP-1 sellers in September 2025, guilty pleas by the founders of another vendor in December 2025 and a competitor's closure in January 2026.

Who the Company Was
- 1Domain registered December 6, 2009; the about page claimed a 1990 founding and directories list 2012. The discrepancy was never explained.
- 2Address: a suite on St. Rose Parkway in Henderson, Nevada, which is an executive-suites mailbox, not a laboratory or warehouse.
- 3Owner named in trade coverage as a biochemist; an estimated three to five employees at closure.
- 4Help-center text claimed peptides "manufactured here in the USA over 16 years" by "WHO/GMP and ISO 9001:2008 approved" manufacturers, with no manufacturer named.
- 5Scale: roughly 990,000 site visits in November 2025 and an estimated $7.45 million in online sales in December 2025, according to third-party traffic estimators quoted by a peptide newsletter; both figures are estimates.
- 6Every product carried the "laboratory research use only, not for human use" disclaimer standard in the category.
Products and Purity
The catalog ran past 100 items: BPC-157, TB-500 and their blend; CJC-1295 with and without DAC, ipamorelin, GHRP-2, GHRP-6, hexarelin, sermorelin, tesamorelin; GHK-Cu, AOD-9604, MOTS-c, selank, semax, epitalon, PT-141, melanotan I and II, NAD+, IGF-1 LR3, thymosin alpha-1, SS-31, KPV, LL-37, DSIP, kisspeptin; capsules of BPC-157, MK-677 and NMN; and, until the compliance removals, semaglutide, tirzepatide and retatrutide.
Every page said "99%+ Purity Guaranteed" and offered a downloadable certificate of analysis, HPLC or mass spectrometry, per batch, with no account needed. The certificates were produced in-house. No third-party laboratory was ever named, there was no signed-certificate portal and no lot-authentication system, and one review site described the documents as "marketing documents, not independent verification". That was the central criticism of the store while it operated, and it is the same gap this site describes for steroid brands that publish their own tests in Pharmaqo test results.
Independent Test Results
An independent testing aggregator collected 123 to 130 third-party results on ten of the store's peptides, with a report dated July 3, 2026. The overall pass rate was about 60%, 78 passes to 52 fails, which the aggregator and a grading site converted to a composite B-minus.
Results by product, as reported by the aggregator and a grading site
Ipamorelin
A, 9.2 of 10 on 9 tests
PT-141
A, 9.1 of 10
BPC-157
A, 7.8 of 10 on 13 samples
GHK-Cu
B, 8.1 of 10
Semaglutide
B, 7.5 of 10; 13 of 15 passed; 78% pass, 4th of 74 vendors; repeated underfill up to 28%
Melanotan II
C, 6.4 of 10
Tirzepatide
D, 6.3 of 10; 10 of 17 passed; 68%, 260th of 277; fails dated May 2025 to March 2026
Tesamorelin
E, 4.9 of 10
CJC-1295
E, 4.3 of 10 on 10 samples
Retatrutide
E; 21 of 41 passed; 56%, 396th of 406; two batches contained no retatrutide at all; fills from 23% under to 46% over
The retatrutide record is the worst of it: two batch numbers tested as containing none of the compound, one February 2025 sample was identified as a different compound, and the aggregator flagged counterfeit stock in November 2025. The aggregator also notes that results dated after the shutdown, April to July 2026, probably involve look-alike stock rather than the company's own, which is a reason to read the pre-March figures as the store's record and the later ones as the clones'.

Prices
Single-vial prices recorded in 2025 to early 2026
BPC-157 5 mg / 10 mg / 15 mg
$59.50 / $100 / $140
TB-500 5 mg
$85
PT-141 10 mg
$55
AOD-9604 6 mg
$65
NAD+ 750 mg
$300
Semaglutide, median
$28.33 per mg
Retatrutide, median
$17.81 per mg
One directory quotes BPC-157 5 mg at $39.99 in March 2026, which is probably an older price. Twenty-vial "Bundle & Save" packs took an automatic 15% off and ran from about $550 to $810; blends cost well above the sum of their parts. Grading sites placed the store 40 to 65% above market, against BPC-157 at $35 and $60 from two cheaper competitors. There was no minimum order; coupons "have no cash value", and an aggregator found twelve affiliate or coupon promoters for the store, nine of them without disclosure, which is worth remembering when reading the "best peptide vendor" lists that still rank it.
Shipping and Payment
The last operational help-center text: United States only, with buyers advised against forwarding services; free four-to-seven-day shipping over $200; USPS Priority two to four days at $15; FedEx two-day $25, or $30 with signature; FedEx overnight $50 or $55; Saturday delivery $74.65 in select areas; noon Pacific cutoff for same-day processing Monday to Friday. Discreet packaging was claimed and buyers consistently praised the speed. A 2021 promotional post claiming free international shipping is contradicted by the policy and is treated here as outdated.
Payment was the store's visible weakness. The help center listed all major cards, Apple Pay, Zelle, ACH and bank transfers, plus Bitcoin, Ethereum, USDT and USDC, with Zelle and bank transfers verified daily between 9 AM and noon Pacific, and a "FLEX Payment" option for "pre-qualified customers or those experiencing checkout issues". Newsletters report that card processors repeatedly cut the company off and that it added Venmo and Cash App as a result, a fact publicly flagged by a well-known podcaster. A directory snapshot from February 2026 lists "credit card only", so what was available changed from month to month, the same instability described for the steroid stores in Steroidify review.
Returns and Refunds
The policy, verbatim from the help center: "Because of our strict quality standards and the nature of products, we cannot accept returns." Replacements were offered only for missing, incorrect or damaged items, and cancellation only before shipment. When the store closed there was no refund process and no communication; customers with paid orders were advised by trade newsletters to file chargebacks, and store credit was lost. That is the same written no-refund position UGFreak takes, set out in UGFreak review, with the difference that a shutdown turned it from a policy into an outcome.
What Buyers Said
- 1No Trustpilot, BBB or Sitejabber profile could be found for the company itself; its scores exist only on peptide directories, most of them affiliate-funded.
- 2Directory scores before closure: 7.0 of 10 "moderate trust" (reputation 8.0, pricing 5.5, certificates 6.0); 7.0 of 10 with support at 6.0 and sentiment "mixed to negative"; a B-plus, the highest in one directory, converted to F on March 14, 2026.
- 3Praise: fast shipping, professional packaging, clear labeling, breadth of catalog, responsive support, more than ten years in operation.
- 4Complaints: premium pricing, in-house-only certificates, no refunds, slow support, doubts about effectiveness, payment rails that kept changing, and the zero-notice shutdown with unfulfilled orders.
- 5Customer ratings on the testing aggregator: retatrutide 4.3 of 5 from 22, tirzepatide 4.9 of 5 from 9, which sit oddly beside the test results for the same products and illustrate why blood work and lab tests, not star ratings, are the measure.
The Clones
Since March 2026 at least four domains have traded on the name. None is affiliated; the company's own notice says so.
- 1A .com with "inc" appended, registered April 17, 2026 through a Hong Kong registrar, with a Florida virtual office, crypto-only checkout, no company registry match, and fraud complaints over Zelle and crypto payments; placed on registrar hold by September 2026.
- 2A .com with "labs" appended: Trustpilot 2.3 from five or six one-star reviews between May and July 2026, losses of $450 and $218 reported, payment requested by Zelle or Apple Cash, orders stuck "On Hold"; reviewers call it a clone and Trustpilot marks the site closed.
- 3A misspelled plural .com: Trustpilot 2.2 from 23 reviews, no verified connection to the company.
- 4A .org flagged by a scam-rating service, and an "official" .us.com address seen in search results, both unverified.
The aggregator's rule is the right one: any active checkout claiming to sell Peptide Sciences stock should be treated as fraudulent. The checks are the ones in the NapsGear official website guide, with one addition that applies to no other store on this site: there is no real site to find.
Verdict
Peptide Sciences was a real, long-running, expensive US vendor whose products tested well on some peptides and badly on others, whose certificates were its own, and whose refund policy was no refunds. It closed without warning in March 2026 and left paid orders behind. The name now belongs to its clones, and the search traffic that still arrives at "Peptide Sciences review" is traffic they are waiting for.
For a buyer who used to order there, the useful part of this record is the test table: the peptides that passed are the ones to look for third-party results on at a replacement vendor, and the ones that failed are where a replacement vendor's own certificate is not enough. Where that leaves the stores this site covers is in NapsGear alternatives.
No. It announced a voluntary shutdown on March 6, 2026 and its domain states that it discontinued all sales that month and has no authorized successor. Sites selling under the name since then are not the company.
It was a real vendor operating since at least 2009 with fast US shipping and in-house purity certificates. Independent tests on 123 to 130 samples passed about 60%: ipamorelin, PT-141 and BPC-157 scored well, retatrutide, CJC-1295 and tesamorelin badly, and two retatrutide batches contained none of the compound.
No refund process was announced. Its policy already excluded returns, and newsletters reported customers with unshipped paid orders being told to pursue card chargebacks. Store credit was lost.
BPC-157 5 mg at $59.50, TB-500 5 mg at $85, PT-141 10 mg at $55, NAD+ 750 mg at $300; semaglutide a median $28.33 per mg. Grading sites put it 40 to 65% above market.
United States only, free over $200 in four to seven days, with USPS Priority at $15 and FedEx two-day and overnight at $25 and $50. Same-day processing before noon Pacific on weekdays.
None now. The original domain shows only a closure notice. A .com with "inc" appended, a .com with "labs" appended, a misspelled plural .com and a .org have all sold under the name since March 2026; two have one- and two-star Trustpilot pages. This site does not link to any of them.
NapsGear.review is an independent review and information website. We are not affiliated with NapsGear, Peptide Sciences, their owners, sellers, suppliers, athletes, payment processors, or support teams. This article is written for informational and review purposes only. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.
Editorial Team
Editorial Staff
Editorial team
Comments (0)
Be the first to comment on this article.